Our findings determined that 6% of the Colombian women with unselected BC had germline mutations in seven of the genes studied, being BRCA2 the gene with the highest frequency of variants and women affected, followed by ATM, BRCA1, PALB2, CHEK2, BARD1 and RAD51D genes. This evidence concerns the gene BRCA2 and breast cancer.